HUMA - Humacyte, Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
1.8 -0.01 (-0.62%)	---	0.0 (0.0%)	0.01 (0.5%)	0.0 (0.0%)	-0.04 (-2.22%)	0.02 (1.07%)	0.02 (1.07%)

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

Market Period: Closed

Earnings & Ratios

Basic EPS:: -0.24
Diluted EPS:: -0.24
Basic P/E:: -7.4538
Diluted P/E:: -7.4538
RSI(14) 1m:: 0.0
VWAP:: 1.79
RVol:: 0.6245

Events

Period	Kind	Movement	Occurred At
1m	Price decrease 1m	1.75 -0.02 (-1.12%)	Oct 15 16:53
1m	Price decrease 1m	1.79 -0.02 (-1.17%)	Oct 15 09:46
1m	Price increase 1m	1.82 +0.02 (+1.11%)	Oct 15 09:42
1m	Price increase 1m	1.8 +0.03 (+1.45%)	Oct 15 09:36
1m	Price decrease 1m	1.77 -0.02 (-1.36%)	Oct 15 09:32